UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018

JAMA ophthalmology, 2020-05, Vol.138 (5), p.439

2020

Volltextzugriff (PDF)

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015

International journal of antimicrobial agents, 2019-04, Vol.53 (4), p.456-466

2019

Volltextzugriff (PDF)

Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program

PloS one, 2018-04, Vol.13 (4), p.e0195281-e0195281

2018

Volltextzugriff (PDF)

In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program

Antimicrobial agents and chemotherapy, 2023-01, Vol.67 (1), p.e0134622-e0134622

2023

Volltextzugriff (PDF)

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

BMC microbiology, 2019-07, Vol.19 (1), p.150-14, Article 150

2019

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

BMC microbiology, 2021-03, Vol.21 (1), p.74-74, Article 74

2021

Volltextzugriff (PDF)

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3606-3610

2015

Volltextzugriff (PDF)

Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases

Journal of medical microbiology, 2018-03, Vol.67 (3), p.289-295

2018

Volltextzugriff (PDF)

Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)

Journal of global antimicrobial resistance., 2020-09, Vol.22, p.738-741

2020

Volltextzugriff (PDF)

Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

Annals of clinical microbiology and antimicrobials, 2006-02, Vol.5 (1), p.2-2, Article 2

2006

Volltextzugriff (PDF)

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3398-3407

2008

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

European journal of clinical microbiology & infectious diseases, 2023-03, Vol.42 (3), p.365-370

2023

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

International journal of infectious diseases, 2022-12, Vol.125, p.250-257

2022

Volltextzugriff (PDF)

Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012–2013)

Clinical therapeutics, 2016-06, Vol.38 (6), p.1510-1521

2016

Volltextzugriff (PDF)

Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe

Diagnostic microbiology and infectious disease, 2015-02, Vol.81 (2), p.112-118

2015

Volltextzugriff (PDF)

Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012–2017

Journal of global antimicrobial resistance., 2021-03, Vol.24, p.316-320

2021

Volltextzugriff (PDF)

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

The Brazilian journal of infectious diseases, 2023-05, Vol.27 (3), p.102759-102759, Article 102759

2023

Volltextzugriff (PDF)

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

Journal of global antimicrobial resistance., 2020-06, Vol.21, p.223-228

2020

Volltextzugriff (PDF)

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

The Brazilian journal of infectious diseases, 2021-11, Vol.25 (6), p.101647-101647, Article 101647

2021

Volltextzugriff (PDF)

Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1295-1299

2004

Volltextzugriff (PDF)

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

The Brazilian journal of infectious diseases, 2017-05, Vol.21 (3), p.343-348

2017

Volltextzugriff (PDF)

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020

The Brazilian journal of infectious diseases, 2023-05, Vol.27 (3), p.102775-102775, Article 102775

2023

Volltextzugriff (PDF)

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Volltextzugriff (PDF)

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1681-1688

2003

Volltextzugriff (PDF)

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Volltextzugriff (PDF)

1 – 25 von 380

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(372)
Mit Volltextzugriff
(361)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(243)
Life Sciences & Biomedicine
(241)
Microbiology
(182)
Humans
(163)
Pharmacology & Pharmacy
(142)
Microbial Sensitivity Tests
(136)
Anti-Bacterial Agents - Pharmacology
(127)
Infectious Diseases
(115)
Biological And Medical Sciences
(89)
Medical Sciences
(83)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(69)
Pharmacology. Drug Treatments
(69)
Antibacterial Agents
(59)
Surveillance
(58)
United States
(54)
Susceptibility
(49)
Pseudomonas Aeruginosa
(47)
Streptococcus Pneumoniae
(46)
Streptococcus Pneumoniae - Drug Effects
(42)
Anti-Bacterial Agents
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015

Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program

In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases

Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)

Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012–2013)

Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe

Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012–2017

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)

Suchergebnisse filtern